 |
Mechanisms of Disease: Antiphospholipid Antibodies -- From Clinical Association to Pathologic Mechanism CME DisclosuresRelease Date: February 19, 2008; Valid for credit through February 19, 2009 |
| Physicians - maximum of 1.0 AMA PRA Category 1 Credit(s)™ for physicians | |
| Contents of This CME Activity | |
| Legal Disclaimer | |
| The material presented here does not necessarily reflect the views of Medscape or companies that support educational programming on www.medscape.com. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity. Copyright © 2008 Medscape. |
|
|
Learning Objectives Upon completion of this activity, participants will be able to: - Describe the clinical features of antiphospholipid syndrome (APS)
- Identify the prevalence of overlapping features of APS and systemic lupus erythematosus
- Identify the infectious disease most likely to be confused
serologically with APS
- List the minimal requirements of the Sapporo classification to be fulfilled for a diagnosis of APS
- Identify the serologic test most likely to be correlated with thrombosis, prognosis, and pregnancy loss in patients with APS
Authors and Disclosures |
 |
Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Medscape, LLC designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Contact This Provider
|
|
